Sable Bio
PrivateLast Round
Seed
Feb 11, 2026
Total Funding Raised
$9.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sable Bio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in February 2026.
Sable Bio is a biotechnology company that provides an AI-powered platform for drug safety assessment and target toxicology analysis in the pharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sable Bio Comparables
Compare Sable Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepCyte | 80% | |
| Inductive Bio | 78% | |
| Metisox | 78% |
For institutional investors. Book with your work email.
Sable Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 11, 2026 | ||||
| Pre Seed | Feb 6, 2024 | ||||
| Seed | Jul 14, 2022 | ||||
| Seed | Feb 27, 2020 | ||||
| Pre Seed | Jun 9, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sable Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XG Ventures | Seed |
| Red Sea Ventures | Seed |
| Outbound Ventures | Seed, Pre Seed |
| Emles | Seed |
| Twenty Two Ventures | Seed |
| Columbia University in the City of New York | Seed |
| GMO VenturePartners | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 99% MoM, reaching 3.8K.
- Feb 6, 2024
$1.9M round led by Episode 1 Ventures.
For institutional investors. Book with your work email.
Sable Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sable Bio's valuation, stock price, and market status.
Is Sable Bio a public or private company?
Sable Bio is a private company.
What is the current stock price of Sable Bio?
Sable Bio is a private company, so its shares have no public market price. Caplight tracks Sable Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sable Bio worth (valuation)?
Valuation information for Sable Bio is not publicly available.
Can I buy Sable Bio stock?
Sable Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sable Bio's last funding round?
Sable Bio's most recent funding round was Seed on February 11, 2026.
Who are the main investors in Sable Bio?
Key investors in Sable Bio include Y Combinator, MMC Ventures, Episode 1 Ventures.
Will Sable Bio IPO soon?
No public IPO plans have been announced for Sable Bio.
How can I track Sable Bio secondary market activity?
Caplight tracks bids, offers, and trades in Sable Bio's shares on secondary markets.